Explore the detailed record of transactions filed by 이채주. Director active across 2 companies, notably 광동제약. Aggregated, 46 filings have been recorded. History available since 27 February 2026. The latest transaction was filed on 27 February 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Declarations 46 total
● Executives · 14 Apr 2026 (filed) · 광동제약 ● 상무이사 · Executives · 27 Feb 2026 · 광동제약 7,868 shares @ ₩7,260.00 0.0000% mcap 100.0% of flow Share DART:20260309001931 Ideal exit: 24 Nov 2026 (T+270) ● 상무이사 · Executives · 23 Jul 2020 · 광동제약 4,666 shares @ ₩7,293.523 0.0000% mcap 100.0% of flow Share DART:20260309001932 ● 상무이사 · Executives · 27 Feb 2026 · 광동제약 5,878 shares @ ₩7,260.00 0.0000% mcap 100.0% of flow Share DART:20260309001928 Ideal exit: 24 Nov 2026 (T+270) ● 전무이사 · Executives · 27 Feb 2026 · 광동제약 6,613 shares @ ₩7,260.00 0.0000% mcap 100.0% of flow Share DART:20260309001933 Ideal exit: 24 Nov 2026 (T+270) ● 전무이사 · Executives · 27 Feb 2026 · 광동제약 5,878 shares @ ₩7,260.00 0.0000% mcap 100.0% of flow Share DART:20260309001913 Ideal exit: 24 Nov 2026 (T+270) ● Executives · 9 Mar 2026 (filed) · 광동제약 115,953 shares DART:20260309001894 ● 대표이사(사장) · Executives · 27 Feb 2026 · 광동제약 7,347 shares @ ₩7,260.00 0.0000% mcap 100.0% of flow Share DART:20260309001897 Ideal exit: 24 Nov 2026 (T+270) ● 전무이사 · Executives · 27 Feb 2026 · 광동제약 5,878 shares @ ₩7,260.00 0.0000% mcap 100.0% of flow Share DART:20260309001921 Ideal exit: 24 Nov 2026 (T+270) ● Executives · 6 Mar 2026 (filed) · 디아이 ● Executives · 20 Jan 2026 (filed)
● Executives · 31 Dec 2025 (filed)
● Executives · 30 Dec 2025 (filed)
● Executives · 5 Dec 2025 (filed)
● Executives · 25 Sept 2025 (filed)
● Executives · 5 Sept 2025 (filed)
● Executives · 10 Jun 2025 (filed)
● Executives · 9 May 2025 (filed)
● Executives · 8 Apr 2025 (filed)
● Executives · 27 Dec 2024 (filed) · 광동제약 ● Executives · 8 Oct 2024 (filed) · 광동제약 50,000 shares DART:20241008000371 Ideal exit: 5 Jul 2025 (T+270) ● Executives · 26 Jul 2024 (filed) · 광동제약 ● Executives · 28 Jun 2024 (filed) · 광동제약 ● Executives · 11 Apr 2024 (filed)
● Executives · 8 Feb 2024 (filed)
25 of 46 declarations
Load more (21 remaining)